43 related articles for article (PubMed ID: 37575726)
1. Pfizer-BioNTech and Sinopharm: A Comparative Study on Post-Vaccination Antibody Titers.
Alqassieh R; Suleiman A; Abu-Halaweh S; Santarisi A; Shatnawi O; Shdaifat L; Tarifi A; Al-Tamimi M; Al-Shudifat AE; Alsmadi H; Al Sharqawi A; Alnawaiseh H; Anasweh Y; Domaidah FA; Jaber HA; Al-Zarir MR; Bsisu I
Vaccines (Basel); 2021 Oct; 9(11):. PubMed ID: 34835153
[TBL] [Abstract][Full Text] [Related]
2. Humoral Response to SARS-CoV-2-Vaccination with BNT162b2 (Pfizer-BioNTech) in Patients on Hemodialysis.
Jahn M; Korth J; Dorsch O; Anastasiou OE; Sorge-Hädicke B; Tyczynski B; Gäckler A; Witzke O; Dittmer U; Dolff S; Wilde B; Kribben A
Vaccines (Basel); 2021 Apr; 9(4):. PubMed ID: 33918085
[TBL] [Abstract][Full Text] [Related]
3. An Unusual Presentation of Erythema Multiforme Following the Administration of Pfizer-BioNTech COVID-19 mRNA Vaccine in a Pediatric Patient.
Alghamdi Y; Abdulghani F; Huwait HF; Abdulghani M; Samarkandy SJ
Cureus; 2024 Apr; 16(4):e58450. PubMed ID: 38765345
[TBL] [Abstract][Full Text] [Related]
4. Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare Workers.
Coggins SA; Laing ED; Olsen CH; Goguet E; Moser M; Jackson-Thompson BM; Samuels EC; Pollett SD; Tribble DR; Davies J; Illinik L; Hollis-Perry M; Maiolatesi SE; Duplessis CA; Ramsey KF; Reyes AE; Alcorta Y; Wong MA; Wang G; Ortega O; Parmelee E; Lindrose AR; Snow AL; Malloy AMW; Letizia AG; Ewing D; Powers JH; Schully KL; Burgess TH; Broder CC; Mitre E
Open Forum Infect Dis; 2022 Jan; 9(1):ofab575. PubMed ID: 35047649
[TBL] [Abstract][Full Text] [Related]
5. A study on the side effects caused by the Pfizer/BioNTech COVID-19 vaccine: Focus on IgG antibodies and serological biomarkers.
Ali KM; Ali AM; Atta PM; Mahmood KI; Rostam HM
Cent Eur J Immunol; 2024; 49(1):2-10. PubMed ID: 38812603
[TBL] [Abstract][Full Text] [Related]
6. Impaired Antibody Response to the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis.
Ammitzbøll C; Bartels LE; Bøgh Andersen J; Risbøl Vils S; Elbaek Mistegård C; Dahl Johannsen A; From Hermansen ML; Kragh Thomsen M; Erikstrup C; Hauge EM; Troldborg A
ACR Open Rheumatol; 2021 Sep; 3(9):622-628. PubMed ID: 34273260
[TBL] [Abstract][Full Text] [Related]
7. Human leukocyte antigen variants associate with BNT162b2 mRNA vaccine response.
Esposito M; Minnai F; Copetti M; Miscio G; Perna R; Piepoli A; De Vincentis G; Benvenuto M; D'Addetta P; Croci S; Baldassarri M; Bruttini M; Fallerini C; Brugnoni R; Cavalcante P; Baggi F; Corsini EMG; Ciusani E; Andreetta F; Dragani TA; Fratelli M; Carella M; Mantegazza RE; Renieri A; Colombo F
Commun Med (Lond); 2024 Apr; 4(1):63. PubMed ID: 38575714
[TBL] [Abstract][Full Text] [Related]
8. Challenges of Storage and Stability of mRNA-Based COVID-19 Vaccines.
Uddin MN; Roni MA
Vaccines (Basel); 2021 Sep; 9(9):. PubMed ID: 34579270
[TBL] [Abstract][Full Text] [Related]
9. Lichenoid cutaneous skin eruption and associated systemic inflammatory response following Pfizer-BioNTech mRNA COVID-19 vaccine administration.
Onn PY; Chang CL
Respirol Case Rep; 2021 Nov; 9(11):e0860. PubMed ID: 34631106
[TBL] [Abstract][Full Text] [Related]
10. Petechiae and Desquamation of Fingers Following Immunization With BTN162b2 Messenger RNA (mRNA) COVID-19 Vaccine.
Irvine NJ; Wiles BL
Cureus; 2021 Aug; 13(8):e16858. PubMed ID: 34513435
[TBL] [Abstract][Full Text] [Related]
11. Time-dependent enhancement of mRNA vaccines by 4-1BB costimulation.
Sanchez S; Dangi T; Awakoaiye B; Irani N; Fourati S; Richner J; Penaloza-MacMaster P
bioRxiv; 2024 Mar; ():. PubMed ID: 38496467
[TBL] [Abstract][Full Text] [Related]
12. Minimal mRNA uptake and inflammatory response to COVID-19 mRNA vaccine exposure in human placental explants.
Gonzalez VJ; Li L; Buarpung S; Prahl M; Robinson JF; Gaw SL
iScience; 2023 Sep; 26(9):107549. PubMed ID: 37664582
[TBL] [Abstract][Full Text] [Related]
13. Response to Comment on "Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines".
Bansal S; Fleming T; Mohanakumar T
J Immunol; 2022 Apr; 208(8):1833-1834. PubMed ID: 35418502
[No Abstract] [Full Text] [Related]
14. The Effect of Third Dose of Pfizer/BioNTech and Moderna COVID-19 mRNA Vaccines on IgG Antibody Titers.
Khuc TA; Pequeno G; Betancourt-Garcia M; Casciato AM; Gomez-Martinez M; Arroyo CD; Pope BD; Narmala S; Rao S
Cureus; 2023 Jul; 15(7):e41696. PubMed ID: 37575726
[TBL] [Abstract][Full Text] [Related]
15. Increasing Levels of Serum Anti-Spike S1-RBD IgG after 120 Days of the Pfizer-BioNTech-mRNA Second Dose Vaccination.
Abdul-Wahab Kadhum A; Rushdi Abdullah A; Mujahid A
Arch Razi Inst; 2023 Jun; 78(3):1071-1075. PubMed ID: 38028836
[TBL] [Abstract][Full Text] [Related]
16. Differences in IgG Antibody Responses following BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines.
Montoya JG; Adams AE; Bonetti V; Deng S; Link NA; Pertsch S; Olson K; Li M; Dillon EC; Frosch DL
Microbiol Spectr; 2021 Dec; 9(3):e0116221. PubMed ID: 34756093
[TBL] [Abstract][Full Text] [Related]
17. Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.
Vinh DC; Gouin JP; Cruz-Santiago D; Canac-Marquis M; Bernier S; Bobeuf F; Sengupta A; Brassard JP; Guerra A; Dziarmaga R; Perez A; Sun Y; Li Y; Roussel L; Langelier MJ; Ke D; Arnold C; Whelan M; Pelchat M; Langlois MA; Zhang X; Mazer BD;
Lancet Healthy Longev; 2022 Mar; 3(3):e166-e175. PubMed ID: 35224524
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the significant decline in humoral immune response six months post-SARS-CoV-2 mRNA vaccination: A systematic review.
Notarte KI; Guerrero-Arguero I; Velasco JV; Ver AT; Santos de Oliveira MH; Catahay JA; Khan MSR; Pastrana A; Juszczyk G; Torrelles JB; Lippi G; Martinez-Sobrido L; Henry BM
J Med Virol; 2022 Jul; 94(7):2939-2961. PubMed ID: 35229324
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
